TABLE 1.
Main dermal filler products discussed in this review, all commonly used in the UK
| Brand | Product | Concentration of HA (mg/ml) | Crosslinking technology | Percent crosslinking | Degree of correction and (site of application) a |
|---|---|---|---|---|---|
| Revolax | Fine | 24 21 | Ursolic acid encapsulation 21 | Unreported | Fine, superficial and lip submucosa (crow's feet, neck, and wrinkles) |
| Deep | 24 21 | Ursolic acid encapsulation | Unreported | Fine to medium, superficial to mid dermis (forehead lines, tear troughs) | |
| Sub‐Q | 24 21 | Ursolic acid encapsulation | Unreported | Moderate to severe, mid to deep dermis (facial contours, cheek, nose, chin) | |
| Teoxane |
Redensity II RHA 1 RHA2 |
15 43 15 44 23 44 |
Standard RHA 33 RHA |
Unreported 1.9% 45 3.6% 45 |
Fine, superficial (tear trough, periorbital regions) Dynamic perioral rhytids and barcode lines Dynamic lip volumization |
| RHA3 | 23 44 | RHA | 6.02% 45 | Moderate to severe, mid to deep dermis (deep wrinkles) | |
| RHA4 | 23 44 | RHA | 6.85% 45 | Moderate to severe, deep dermis to subcutaneous (cheek, chin, temples) | |
| Ultra‐deep | 25 14 | Standard | 10% 45 | Severe, deep dermis (chin, cheekbones, jawline) | |
| Juvéderm | Vobella | 15 44 | Vycross 44 | 6.61% 45 | Fine to medium, superficial to mid dermis and lip submucosa (lateral canthal lines, tear troughs, lips) |
| Volift | 17.5 44 | Vycross | 7.73% 45 | Medium, midface volume loss and cheek augmentation, deep dermis to subcutaneous (cheek, facial contours, lips) | |
| Voluma | 20 44 | Vycross | 7.36% 45 | Medium, midface volume loss and cheek augmentation, deep dermis to subcutaneous (temple and lateral brow, medial brow, cheek, jawline) | |
| Volux | 25 44 | Vycross | 9.4% 45 | Moderate to severe, deep dermis (temple and lateral brow, medial brow, cheekbones, jawline) | |
| Restylane | Fynesse | 20 44 | OBT 32 | 0.1%–5% 19 | Fine to medium, superficial to mid dermis and lip submucosa (nasolabial folds, lips) |
| Volyme | 20 44 | OBT | 0.1%–5% 19 | Moderate to severe, deep dermis to subcutaneous (temple and lateral brow, cheek, chin) | |
| Refyne | 20 44 | OBT | 6% 30 | Moderate to severe, mid to deep dermis (lateral canthal lines, tear trough) | |
| Defyne | 20 44 | OBT | 8% 30 | Moderate to severe, mid to deep dermis (temple and lateral brow, cheek, medial brow, jawline) |
Abbreviation: HA, hyaluronic acid.
a
Based on product information provided by manufacturers.